Competition & Peer Data API & CSV Delivery

Vsee Health Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Vsee Health Inc (VSEE) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q2 2026
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
vs 100.00 % a year ago
Revenue Growth Y/Y
-39.66 %
Q2 2026
Net Margin
54.25 %
Q2 2026

Key Findings: Vsee Health Inc vs Its Competitors

  • TTM: Trailing 12-month revenue of 11M vs -M combined for tracked competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is decelerating (-41.9% annualized vs trailing 12 months).
  • Scale: Vsee Health Inc ranks #203 of 247 companies by market capitalization in the Medical Equipment & Supplies industry, holding 0.0% of industry market cap.
  • Peer revenue share: Vsee Health Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

VSEE Sales vs. its Competitors, Q2 2026

Vsee Health Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/VSEE/competitors
https://api.csimarket.com/api/v1/companies/VSEE/relationships
https://api.csimarket.com/api/v1/companies/VSEE/similar
Programmatic access for models, analytics, and integration workflows.

For context: the Medical Equipment & Supplies industry grew revenue 15.0% year over year, combined, vs -39.7% for Vsee Health Inc. Vsee Health Inc's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.

Vsee Health Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Vsee Health Inc No No No No
High-Confidence Competitors (9) 56% 67% 44% 11%
Similar-Size Competitors (10) 20% 80% 80% 33%
Similar Growth & Profitability (8) 0.00 % (0 of 8) 37.50 % (3 of 8) 25.00 % (2 of 8) 37.50 % (3 of 8)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q2 2026

100%market share
  • Vsee Health Inc100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Vsee Health Inc and its 0 tracked competitors.

See Vsee Health Inc's full market share breakdown »

VSEE Stock Performance relative to its Competitors

VSEE Competitors (weighted) Percent change over the selected range

Vsee Health Inc's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.
33.3%beat U.S.A. 500
High-Confidence
(3 of 9)
0%beat U.S.A. 500
Similar-Size
(0 of 4)
0%beat U.S.A. 500
Similar Growth & Profitability
(0 of 3)
Entity TTM Share Price Return
(group: median)
vs U.S.A. 500
Vsee Health Inc - -
Competitors combined (0) 40.4% 63.2%
High-Confidence Competitors (9) 40.4% 63.2%
Similar-Size Competitors (4) 40.4% 63.2%
Similar Growth & Profitability (3) 40.4% 63.2%
Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Vsee Health Inc's competitor groups requires a Commercial License.

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

VSEE Stock Performance relative to High-Confidence Competitors

VSEE High-Confidence Competitors (equal-weighted, 9) Percent change over the selected range

VSEE Stock Performance relative to Similar-Size Competitors

VSEE Similar-Size Competitors (equal-weighted, 10) Percent change over the selected range

VSEE Stock Performance relative to Similar Growth & Profitability Competitors

VSEE Similar Growth & Profitability Competitors (equal-weighted, 8) Percent change over the selected range

Vsee Health Inc's Comment on Competition and Industry Peers

The company identifies its competitors as entities involved in developing and marketing virtual care technology or providing virtual care services. Key competitive factors include software as a service, operational experience, customer service, technology quality, and reputation. Competitors in telehealth and specialty medical services include MDLive, Inc. (owned by Cigna), American Well Corporation, Included Health, and Accolade, Inc. In the neuro and ICU specialty sectors, competitors include NeuroCall, Ceribell, and Specialist on Call. Technology solution competitors comprise American Well Corporation, MDLive, Teladoc, and smaller technology providers. VSee and iDoc also compete with large health plans that have in-house platforms, as well as major technology and retail companies such as Google, Microsoft, Amazon, and Walmart, which may develop or acquire virtual care solutions. Many competitors have longer business histories, substantial financial resources, established customer relationships, and public financial structures that provide access to significant capital. The company anticipates intense and increasing competition as the virtual care industry evolves.

Vsee Health Inc's Competitors Named by the Company

Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.
Competitor Basis Confidence Active Sources
MDLive, Inc. Named by the company 85% 2022 to 2026 3
Walmart Named by the company 85% 2022 to 2026 3
Amazon Named by the company 85% 2022 to 2026 3
iDoc Named by the company 85% 2022 to 2026 3
Specialist on Call Named by the company 85% 2022 to 2026 3
Cigna Named by the company 85% 2022 to 2026 3
Microsoft Named by the company 85% 2022 to 2026 3
American Well Corporation Named by the company 85% 2022 to 2026 3
Included Health Named by the company 85% 2022 to 2026 3
Teladoc Named by the company 85% 2022 to 2026 3
Accolade, Inc. Named by the company 85% 2022 to 2026 3
Google Named by the company 85% 2022 to 2026 3
NeuroCall Named by the company 85% 2022 to 2026 3
Ceribell Named by the company 85% 2022 to 2026 3
Competitor Evidence Detail

Filing basis, confidence, active dates and source counts for Vsee Health Inc's named competitors require a Commercial License.

Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.